Suchergebnisse - "Chen, Mengnuo"

PubPharm (12)

1

Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse

enthalten in: Cell reports. Medicine | 2024

von Chen, M. | Mainardi, S. | Lieftink, C. | +20

2

Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2

enthalten in: JHEP reports : innovation in hepatology | 2023

von Wang, S. | Zhou, Y. | Yu, R. | +22

3

A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer

enthalten in: bioRxiv.org | 2022

von Yang, C. | Chen, M. | Wang, S. | +8

4

A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer

enthalten in: eLife | 2022

von Yang, C. | Zhang, H. | Chen, M. | +10

5

Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancers

enthalten in: Cell reports | 2022

von Shen, J. | Yang, C. | Zhang, M. | +14

6

Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer

enthalten in: Communications biology | 2021

von Cheng, C. | Tsang, F. | Wei, L. | +8

7

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

enthalten in: Molecular cancer | 2020

von Chen, M. | Wong, C.

8

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

enthalten in: Molecular cancer | 2020

von Chen, M. | Wong, C.

9

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

enthalten in: Molecular cancer | 2020

von Chen, M. | Wong, C.

10

Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression

enthalten in: Gut | 2020

von Shen, J. | Chen, M. | Lee, D. | +9

CommentIn: Gut. 2020 Feb;69(2):195-196. - PMID 31615836